Based on a multidisciplinary approach consisting of bulk RNA sequencing (RNA-seq), ATAC sequencing (ATAC-seq), and single-cell RNA sequencing (scRNA-seq), we found that Ly6d was significantly associated with NAFLD progression in both humans and mice. The gene discussed is LY6D; the disease is metabolic dysfunction-associated steatotic liver disease.